Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Normal tissue tolerance to intraoperative radiotherapy.

William F Sindelar1, Timothy J Kinsella

  • 1Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Surgical Oncology Clinics of North America
|March 3, 2004
PubMed
Summary

Intraoperative radiation therapy (IORT) tissue tolerance, validated by canine models, guides clinical practice. Careful IORT dose management is crucial for sensitive organs to maximize tumor kill and minimize normal tissue damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case report of typhlitis during novel use of ropidoxuridine-capecitabine-radiotherapy for treatment-naïve rectal cancer.

Cancer chemotherapy and pharmacology·2023
Same author

Editorial: 365 days of progress in radiation oncology.

Frontiers in oncology·2023
Same author

National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.

Cancer·2019
Same author

Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases.

Advances in radiation oncology·2018
Same author

Management approach for recurrent brain metastases following upfront radiosurgery may affect risk of subsequent radiation necrosis.

Advances in radiation oncology·2017
Same author

Patients with Long-Term Control of Systemic Disease Are a Favorable Prognostic Group for Treatment of Brain Metastases with Stereotactic Radiosurgery Alone.

World neurosurgery·2016

Area of Science:

  • Radiation Oncology
  • Experimental Pathology
  • Surgical Oncology

Background:

  • Intraoperative radiation therapy (IORT) is a technique used in cancer treatment.
  • Experimental data, primarily from canine models, has informed IORT tissue tolerance guidelines.
  • Understanding species-specific tissue responses is crucial for safe and effective IORT application.

Purpose of the Study:

  • To review and validate the use of canine models for predicting human tissue tolerance to IORT.
  • To elucidate the cellular and vascular mechanisms underlying radiation-induced tissue toxicity.
  • To establish guidelines for safe IORT dosage based on tissue sensitivity and anatomical location.

Main Methods:

  • Review of accumulated experimental evidence on IORT tissue tolerance.

Related Experiment Videos

  • Analysis of data from canine models and comparison with clinical outcomes.
  • Examination of cellular radiation effects, particularly DNA damage and proliferation.
  • Pathological assessment of radiation-induced vascular changes and ischemia.

    • Main Results:

    • Canine models are validated as representative of human tissue responses to IORT.
    • Proliferating tissues are most radiosensitive, showing early toxicity.
    • Non-proliferating tissues may exhibit delayed toxicity due to vascular damage and ischemia.
    • Doses up to 25 Gy are generally tolerated without significant toxicity in most tissues.
    • Critical structures like vasculature, GI tract, ureters, nerves, and CNS require careful dose monitoring.

    Conclusions:

    • The canine model effectively predicts human tissue tolerance to IORT.
    • Vascular damage is a common mechanism for late radiation toxicity.
    • IORT dose must be optimized to target tumors while sparing critical normal tissues, especially vital organs.